Want to join the conversation?
$COO expects CooperVision's FY16 revenue to be $1.545-1.567Bil or 5.5-7.0% constant currency growth and CooperSurgical's revenue to be $384-393MM or 6-8% pro forma growth. Non-GAAP GM is expected to be about 63%. Company expects OpEx to be about 39%, operating margin to be about 24% and interest expense to be about $28MM in FY16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?